The Lancet NeurologyVolume 16, Issue 2, February 2017, Page 97EditorialSolanezumab: too late in mild Alzheimer's disease?Author links open overlay panelThe Lancet NeurologyShow moreShareCitehttps://doi.org/10.1016/S1474-4422(16)30395-7Get rights and contentRecommended articlesReferences (0)Cited by (0)View full text© 2016 Elsevier Ltd. All rights reserved.